This tattoo-like sensor measures blood glucose levels non-invasively
[Image from UC San Diego]Diabetes tracking can be a scary and tedious task, but University of California at San Diego researchers have developed a needless glucose monitor tattoo sensor that measures insulin levels through sweat on the skin. There are approximately 30.3 million people living with diabetes in the U.S., according to the American Diabetes Association. Monitoring blood sugar levels is an important part of managing their condition. For people like Angela Valdez, that daily task is avoided because of the traditional pricking of the finger. “I don’t handle monitoring my diabetes as I should,” sa...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Diabetes blood glucose monitoring University of California at San Diego Source Type: news

Beta Bionics wins FDA nod for home-use trial of artificial pancreas tech
Beta Bionics said this week that it won FDA approval to start recruiting patients with Type I diabetes for home-use studies of its iLet bionic pancreas system. The trial is slated to test Novo Nordisk’s fast-acting insulin, Fiasp, with the company’s autonomous infusion pump in adults with Type I diabetes. The study will also evaluate insulin lispro and conventional insulin aspart combined with the iLet system in adults and kids with Type I diabetes, according to Beta Bionics. Get the full story at our sister site, Drug Delivery Business News. The post Beta Bionics wins FDA nod for home-use trial of artificial p...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Beta Bionics Eli Lilly & Co. Novo Nordisk Source Type: news

Maqui berries and cloves can control excessive blood sugar spikes
(Natural News) It’s normal for blood sugar (glucose) levels to increase after a hearty meal. This triggers the release of insulin, a type of hormone that helps your body convert glucose into energy. However, excessive and repeated increase of glucose, called blood sugar spikes, can be potentially life-threatening. Now studies support the ability of extracts from two... (Source: NaturalNews.com)
Source: NaturalNews.com - May 23, 2018 Category: Consumer Health News Source Type: news

Combining AI and CGM to Make a Bionic Pancreas
A startup company is combining artificial intelligence (AI) and glucose monitoring to develop what is being called a bionic pancreas. Beta Bionics has received FDA approval to begin recruitment for the home-use studies testing an insulin-only configuration of the iLet bionic pancreas system. The U.S.-based multicenter, multi-arm, cross-over, clinical will test Novo Nordisk’s recently approved, insulin called Fiasp with the iLet bionic pancreas system in adults with type 1 diabetes, and insulin lispro and conventional insulin aspart using the iLet in adults and children with type 1 diabetes. “The device is about...
Source: MDDI - May 22, 2018 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

Medical News Today: Are apples good for diabetes?
A person with diabetes must monitor the carbohydrate and sugar in their diet. Although apples contain these compounds, they are a healthful choice for people with both type 1 and type 2 diabetes. In this article, find out the effects of apples on blood sugar and insulin levels, plus other fruits to eat for diabetes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 22, 2018 Category: Consumer Health News Tags: Diabetes Source Type: news

Safe driving practices and factors associated with motor-vehicle collisions among people with insulin-treated diabetes mellitus: results from the Diabetes and Driving (DAD) study - Almigbal TH, Alfaifi AA, Aleid MA, Billah B, Alramadan MJ, Sheshah E, AlMogbel TA, Aldekhayel GA, Batais MA.
INTRODUCTION: The aim of this study was to assess the prevalence of people with insulin-treated diabetes mellitus (ITDM) who have discussed issues related to diabetes and driving with their health care providers (HCPs). We also sought to determine the safe... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Valeritas inks distro deal for V-Go device in Austria, Germany
Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Med Trust to commercialize its V-Go insulin delivery device in Austria and Germany. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, quality management and manufacturing. Med Trust will take over the sales, marketing and distribution activities related to the V-Go wearable device in Austria and Germany, the companies reported. Get the full story at our sister site, Drug Delivery News. The post Valeritas inks distro deal for V-Go device in Austria, Germany appeared firs...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Distribution Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Fasting diets may raise risk of diabetes, researchers warn
New study also suggests regimes that include intermittent fasting may cause other long-term health problemsFasting every other day to lose weight could have damaging side effects. That is the conclusion of a group of scientists speaking this weekend at the European Society of Endocrinology ’s annual meeting.Their findings suggest that fasting-based diets may impair the action of sugar-regulating hormone insulin, and lead to increased risk of diabetes. Care should be taken before starting such programmes, say researchers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 20, 2018 Category: Science Authors: Robin McKie, science editor Tags: Diabetes Medical research Diets and dieting Life and style Society UK news Science Source Type: news

Could intermittent fasting diets increase diabetes risk?
(European Society of Endocrinology) Fasting every other day to lose weight impairs the action of sugar-regulating hormone, insulin, which may increase diabetes risk, according to data presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. These findings suggest that fasting-based diets may be associated with long-term health risks and careful consideration should be made before starting such weight loss programs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2018 Category: International Medicine & Public Health Source Type: news

Valeritas touts new data for insulin delivery device
Valeritas (NSDQ:VLRX) touted data today from two new studies of its V-Go wearable insulin delivery device in patients with Type II diabetes. In one three-month evaluation of 60 people with Type II diabetes, researchers assessed if using V-Go could improve glycemic control in patients who were uncontrolled on prior treatment regimens. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas touts new data for insulin delivery device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 18, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Diabetes testing kits are urgently recalled amid fears they give false readings
Dan Howarth, head of care at Diabetes UK, said inaccurate readings could mean patients over or under-dose with insulin, which can cause problems with hyper and hypoglycaemia. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2018 Category: Consumer Health News Source Type: news

CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs CMS Publicizes Costliest Increases for Medicare, Medicaid Drugs
Medicare and Medicaid have faced persistent double-digit increases in the prices of insulin products, as well as notable jumps in the cost of other well-established medicines dating to the 1990s.Medscape Medical News (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - May 17, 2018 Category: Pharmaceuticals Tags: Family Medicine/Primary Care News Source Type: news

Diabetes blood test 'could mean end to daily insulin jabs'
Doctors in Edinburgh say a simple blood test has identified previously unrecognised variations in Type 1 diabetes. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 16, 2018 Category: Consumer Health News Source Type: news

6 Ways to Make Your Coffee Even Healthier
This article originally appeared on Health.com (Source: TIME: Health)
Source: TIME: Health - May 15, 2018 Category: Consumer Health News Authors: Cynthia Sass / Health.com Tags: Uncategorized Diet/Nutrition healthytime onetime Source Type: news

Valeritas & #226; �(TM) V-Go & #194; & #174; Wearable Insulin Delivery Device Results in ...
BRIDGEWATER, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today the publication last week of a manuscript titled“Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin...This story is related to the following:Medical Devices (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - May 15, 2018 Category: Medical Devices Source Type: news

Should You Stop Wearing Sunscreen To Get More Vitamin D? Here ’s What a Doctor Says
Last year, a study published in The Journal of the American Osteopathic Association made headlines when it asserted that sunscreen use is partially to blame for widespread vitamin D deficiency worldwide. The research raised questions, given that consistently wearing sunscreen is one of the most common pieces of advice from physicians. Should the risk of vitamin D deficiency — which can lead to brittle bones and has been associated with insulin resistance, high blood pressure and decreased immune function, among other issues — overshadow years of that advice? Not according to Dr. Victoria Werth, a professor of d...
Source: TIME: Health - May 14, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Diabetes teams must be fully staffed to cut insulin errors, says charity
Insulin errors are still a “worrying problem” in hospitals across England and Wales, according to the charity Diabetes UK, which says diabetes inpatient teams must be “fully staffed” to ensure safe care. (Source: Nursing Times)
Source: Nursing Times - May 14, 2018 Category: Nursing Source Type: news

Patients, health care workers call for affordable insulin
Activists are rallying in Massachusetts, demanding more affordable insulin (Source: ABC News: Health)
Source: ABC News: Health - May 12, 2018 Category: Consumer Health News Tags: Health Source Type: news

Diabetes: The lifelong condition explained
DIABETES is a lifelong condition that causes blood sugar levels to be too high. Usually someone's blood sugar level is regulated by the pancreas, which releases a hormone called insulin to allow the glucose in our blood to enter our cells and fuel our bodies. (Source: Daily Express - Health)
Source: Daily Express - Health - May 11, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Causes and treatment of a black neck
Dark or black patches on the neck can be troubling. In this article, we look at the possible causes for a black neck or hyperpigmentation, including fungal infections, dermatitis neglecta, and high blood insulin levels. We also discuss treatment options and which home remedies can prevent black neck in the future. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 11, 2018 Category: Consumer Health News Tags: Dermatology Source Type: news

Is Meta-Analysis a Sign of Something Big on the Horizon for GID?
All signs are pointing to something big on the horizon for GI Dynamics and its embattled obesity and type 2 diabetes treatment technology. The most recent guidepost from the Lexington, MA-based company came Thursday, when it announced results were being published from a meta-analysis of the EndoBarrier. Results show the device was able to impact weight loss and insulin resistance improvement. The research is titled “Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes,” an...
Source: MDDI - May 10, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

Pancreatic cancer breakthrough: New treatment hope for fifth biggest cancer killer in UK
PANCREATIC cancer symptoms include stomach pain, weight loss and nausea or vomiting. It affects the pancreas, which produces the hormone insulin that regulates blood sugar levels. The fifth biggest cancer in the UK, scientists have just discovered a way to slow the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2018 Category: Consumer Health News Source Type: news

GI Dynamics touts insulin resistance improvement, weight loss in EndoBarrier meta-analysis
This study presents the most comprehensive EndoBarrier meta-analysis we have seen and this type of data is indicative of EndoBarrier’s highly impactful clinical utility,” prez & CEO Scott Schorer said in a press release. Earlier this week, GI Dynamics announced it inked a binding commitment for a $1.8 million financing deal with Crystal Amber Fund Limited. The post GI Dynamics touts insulin resistance improvement, weight loss in EndoBarrier meta-analysis appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Weight loss GI Dynamics Source Type: news

High efficiency synthesis of insulin by self-assembly based organic chemistry
(Tohoku University) Researchers have succeeded in efficiently synthesizing insulin by using only chemical processes based on organic synthesis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2018 Category: International Medicine & Public Health Source Type: news

Senate Hearing, ADA, Address Insulin Prices for Diabetes Patients Senate Hearing, ADA, Address Insulin Prices for Diabetes Patients
In a white paper and Senate testimony, the ADA has called for greater transparency at all stages of insulin pricing to help minimize cost for patients with diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 9, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

The rising cost of insulin: "Horror stories every day"
As insulin prices surge, a mother recounts the financial squeeze that led to her son's death and that imperils other diabetics (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 9, 2018 Category: Consumer Health News Source Type: news

Senators Probe'Enormous' Insulin Price Spikes
(MedPage Today) -- Complicated pricing system makes it hard to determine who profits (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 8, 2018 Category: Primary Care Source Type: news

How Bigfoot Biomedical ’s CEO wants to boost diabetes management
Jeffrey Brewer faced the biggest challenge of his life when his 7-year-old son Sean received a diabetes diagnosis in 2002: Diabetes became the new focus for Brewer’s energy. In his role as CEO at JDRF (formerly the Juvenile Diabetes Research Foundation) between 2011 and 2014, Brewer forged financial partnerships with industry to drive the development of insulin delivery and glucose monitoring technologies. He joined the founding of Bigfoot Biomedical in 2014 because he felt that industry could and should do more to marry the best of our technologies to automate diabetes management and make them available to the great...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Bigfoot Biomedical Source Type: news

How a Low-Carb Diet Might Aid People With Type 1 Diabetes
Children and adults with Type 1 diabetes who followed a low-carb, high-protein diet had “ exceptional ” blood sugar control and low rates of complications. (Source: NYT Health)
Source: NYT Health - May 7, 2018 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Diabetes Diet and Nutrition Carbohydrates Children and Childhood Insulin Source Type: news

Frozen Embryo Transfer Risks; PCOS Awareness Month; Rising Insulin Costs
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 4, 2018 Category: American Health Source Type: news

Reprogrammed cells could be used to treat diabetes
Mouse pancreatic duct cells were genetically reprogrammedin vivo to be beta islet like cells and produce insulin, according to a study published inMolecular Therapy.The Scientist (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 4, 2018 Category: Endocrinology Source Type: news

Diabetes: Try this breakfast to slash blood sugar levels
DIABETES can be present at birth, type 1 diabetes, or develop later in life, type 2 diabetes. It is caused by problems with the hormone insulin, meaning the body cannot remove enough sugar from the blood. Treatment often involves lifestyle and diet changes to combat blood sugar levels. You should switch to this breakfast to help control the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 4, 2018 Category: Consumer Health News Source Type: news

Diabetes: Switch to this yummy food to slash blood sugar levels
DIABETES can be present at birth, type 1 diabetes, or develop later in life, type 2 diabetes. It is caused by problems with the hormone insulin, meaning the body cannot remove enough sugar from the blood. Treatment often involves lifestyle and diet changes to combat blood sugar levels. You should switch to this to help control the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 4, 2018 Category: Consumer Health News Source Type: news

Diabetes: Switch to this food to slash blood sugar levels
DIABETES can be present at birth, type 1 diabetes, or develop later in life, type 2 diabetes. It is caused by problems with the hormone insulin, meaning the body cannot remove enough sugar from the blood. Treatment often involves lifestyle and diet changes to combat blood sugar levels. You should switch to this breakfast to help control the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 4, 2018 Category: Consumer Health News Source Type: news

Is DexCom Really Winning on the CGM Battlefield?
The continuous glucose monitoring (CGM) market is a great example of the sentiment that competition breeds innovation. Last year Abbott took the market by storm, first by winning a key partnership with Bigfoot Biomedical, and later by earning  FDA approval for its FreeStyle Libre Flash glucose monitoring system as a replacement for blood glucose monitoring (BGM) for adults. That win has carried over into 2018 as Abbott's diabetes care sales grew more than 30% in the first quarter, driven by Freestyle Libre, Abbott CEO Miles White said during the company's most recent earnings call, according to SeekingAlpha trans...
Source: MDDI - May 3, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Insulet inks partnerships to expand into Europe
Insulet (NSDQ:PODD) said today that it inked deals with two partners, Theras Group and Nordic Infucare, to distribute its tubeless insulin pump, Omnipod, in Italy and the Nordic markets starting July 1. According to the agreements, both distributors will provide sales, marketing and customer support for Omnipod users and providers in Italy and the Nordic markets. No financial terms of the deals were disclosed. Get the full story at our sister site, Drug Delivery Business News. The post Insulet inks partnerships to expand into Europe appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Insulet Source Type: news

Reprogrammed Cells Treat Diabetes in Mice
Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo intoβ-like cells that secrete insulin and improve diabetes symptoms. (Source: The Scientist)
Source: The Scientist - May 2, 2018 Category: Science Tags: Daily News Source Type: news

Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden and consequences of hypoglycaemia in diabetes. Diabetes is a global epidemic, currently affecting around 60 million people in Europe. Hypoglycaemia is a common and serious complication of diabetes, particularly affecting people with diabetes on insulin therapy; very low levels of blood glucose can lead to cognitive decline, cardiovascular events and even death. (Source: World Pharma News)
Source: World Pharma News - May 2, 2018 Category: Pharmaceuticals Tags: Featured Novo Nordisk Business and Industry Source Type: news

Assessment & Treatment of Five Diabetic Emergencies
Patients experiencing a diabetic emergency should be placed on a cardiac monitor due to the potential for severe electrolyte disturbances. Photos courtesy Nashville Fire Department EMS calls for patients with diabetes are common for many reasons, including their increased risk for cardiac disease, cerebrovascular disease, pneumonia, infection and their many diabetic complications. Knowing and recognizing common emergencies encountered in diabetics is important due to both their frequency and that they are often life-threatening. In this article, we focus on five diabetic emergencies: 1) diabetic ketoacidosis (DKA); 2) h...
Source: JEMS Patient Care - May 2, 2018 Category: Emergency Medicine Authors: H. Evan Dingle, MD Tags: Patient Care Source Type: news

Risk factors involved in the early onset and severity of childhood obesity
(Frontiers) A family history of obesity, high blood pressure and lipid levels, type 2 diabetes and coronary heart disease should all be considered high risk factors for the severity and early onset of childhood obesity, reveals a new study. The study, which assessed these risk factors together from children's parents, siblings and grandparents, also finds the most severely obese children -- even the very young -- show insulin resistance, which can lead to the development of type 2 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2018 Category: International Medicine & Public Health Source Type: news

Glyburide Not Noninferior to Insulin for Gestational Diabetes
TUESDAY, May 1, 2018 -- For women with gestational diabetes, glyburide is not noninferior to insulin, according to a study published in the May 1 issue of the Journal of the American Medical Association. Marie-Victoire S énat, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 1, 2018 Category: Pharmaceuticals Source Type: news

Glyburide Should Not Be First-Line for Gestational Diabetes Glyburide Should Not Be First-Line for Gestational Diabetes
Noninferiority study suggests glyburide may be associated with up to a 10.5% increase in perinatal complications compared with insulin treatment of gestational diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What's the Best First-Line Tx for Gestational Diabetes? (CME/CE)
(MedPage Today) -- Glyburide versus subcutaneous insulin did not result in a greater frequency of perinatal complications (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 1, 2018 Category: Cardiology Source Type: news

Pharma's Opioid CME; $3M Research Breach; Novo's Insulin Pushback
(MedPage Today) -- the past week of investigations into healthcare (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 1, 2018 Category: Urology & Nephrology Source Type: news

Valeritas Presented New Data Demonstrating use of V-Go & #194; & #174; Wearable Insulin ...
BRIDGEWATER, N.J., April 30, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, last week presented positive findings from a new study during the poster presentations at the AMCP Managed Care and Specialty Pharmacy Annual Meeting held in Boston,...This story is related to the following:Medical Devices | (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - May 1, 2018 Category: Medical Devices Source Type: news

Tandem wins CE Mark for t:slim X2 insulin pump
Tandem Diabetes Care (NSDQ:TNDM) said today that its t:slim X2 insulin pump won CE Mark clearance in the European Union. The San Diego, Calif.-based company plans to start selling the device in international markets in the second half of 2018. Tandem’s latest drug-pump won FDA approval in August last year. Get the full story at our sister site, Drug Delivery Business News. The post Tandem wins CE Mark for t:slim X2 insulin pump appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Wall Street Beat Dexcom tandemdiabetes Source Type: news

Eating a lot of processed meat increases your risk of non-alcoholic fatty liver disease and insulin resistance
(Natural News) Researchers have found another reason why eating a lot of processed meat is bad: It increases the risk of non-alcoholic fatty liver disease (NAFLD) and insulin resistance, according to a study published in the Journal of Hepatology. These results add to the increasing amount of evidence on the harmful effects of eating red... (Source: NaturalNews.com)
Source: NaturalNews.com - April 30, 2018 Category: Consumer Health News Source Type: news

Sales for Tandem Diabetes Care climb 44% in Q1
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell -3% today after the insulin pump maker topped revenue expectations, but missed earnings estimates on Wall Street with its first-quarter results. The San Diego, Calif.-based company posted a net loss of -$32.7 million, or -$1.82 per share, on sales of $27.3 million for the 3 months ended March 31, for bottom-line loss of -37% on sales growth of 44% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Sales for Tandem Diabetes Care climb 44% in Q1 appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - April 27, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat tandemdiabetes Source Type: news

Rx Shorts: Long-acting Insulin Confusion
New long-acting insulin products are winning preferred formulary status, pushing old standards aside. Here, pointers on the new options.   (Source: ConsultantLive)
Source: ConsultantLive - April 27, 2018 Category: Internal Medicine Authors: Matthew Baker, PharmD Tags: Diabetes Source Type: news

Mechanism that reduces insulin effectiveness identified
A study, published inDiabetes, reports that cell signaling proteins released by adipose tissue can reduce the effectiveness of insulin.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 27, 2018 Category: Endocrinology Source Type: news